Immunitybio, Inc. (IBRX)

Last Three Months

28-Jan-24 -- 27-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

14

0

3

+1

0

+2

0

+3

Two Year Chart

28-Apr-22 -- 27-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Feb-24 7:33 PM View:	31-Jan-24 Payment of Exercise ($90.17K)	Sachs David C. Chief Financial Officer		Immunitybio, Inc. - IBRX	31% 141.93K to 185.84K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 7:38 PM View:	31-Jan-24 Payment of Exercise ($74.24K)	Simon Barry J. Director		Immunitybio, Inc. - IBRX	1% 3.09M to 3.12M	0	0	--	--	Show Txns Hide Txns

06-Feb-24 9:14 PM View:	05-Feb-24 Payment of Exercise ($174.39K)	Adcock Richard CEO & President Director		Immunitybio, Inc. - IBRX	20% 202.97K to 243.14K	0	0	--	--	Show Txns Hide Txns

02-Feb-24 7:32 PM View:	31-Jan-24 Payment of Exercise ($45.26K)	Gallagher Regan J Chief Accounting Officer		Immunitybio, Inc. - IBRX	26% 74.93K to 94.33K	0	0	--	--	Show Txns Hide Txns